4230 related articles for article (PubMed ID: 6445371)
21. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
Okafuji K; Kaku K; Seguchi M; Tanaka H; Azuno Y; Kaneko T
Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
[TBL] [Abstract][Full Text] [Related]
22. Ionizing radiation-induced apoptosis and DNA repair in murine erythroleukemia cells.
Di Pietro R; Centurione L; Santavenere E; Centurione MA; Sanità Di Toppi G; Zamai L; Rana R
Scanning Microsc; 1996; 10(1):253-9. PubMed ID: 9813610
[TBL] [Abstract][Full Text] [Related]
23. Role of nonhemoglobin heme accumulation in the terminal differentiation of Friend erythroleukemia cells.
Lo SC; Aft R; Mueller GC
Cancer Res; 1981 Mar; 41(3):864-70. PubMed ID: 6936076
[TBL] [Abstract][Full Text] [Related]
24. Reversible suppression of malignancy and differentiation of melanoma cells.
Silagi S
Am J Pathol; 1977 Dec; 89(3):671-84. PubMed ID: 596422
[TBL] [Abstract][Full Text] [Related]
25. Arrest of amelogenin transcriptional activation in bromodeoxyuridine-treated developing mouse molars in vitro.
Couwenhoven RI; Schwartz SA; Snead ML
J Craniofac Genet Dev Biol; 1993; 13(4):259-69. PubMed ID: 8288733
[TBL] [Abstract][Full Text] [Related]
26. The BrdU content of DNA is decreased during reversal of inhibition of myogenesis by deoxycytidine.
Wright WE
Somatic Cell Genet; 1982 Sep; 8(5):547-55. PubMed ID: 7135161
[TBL] [Abstract][Full Text] [Related]
27. [Changes, during a synchronous cell cycle, of the level of incorporation of 5-bromodeoxyuridine into DNA of chick embryo fibroblasts].
Hartmann C; Rode A
C R Seances Acad Sci III; 1982 Sep; 295(2):69-72. PubMed ID: 6816402
[TBL] [Abstract][Full Text] [Related]
28. Dissociation of hemoglobin accumulation and commitment during murine erythroleukemia cell differentiation by treatment with imidazole.
Gusella JF; Tsiftsoglou AS; Volloch V; Weil SC; Neumann J; Housman DE
J Cell Physiol; 1982 Oct; 113(1):179-85. PubMed ID: 6957412
[TBL] [Abstract][Full Text] [Related]
29. Interaction of monoclonal antibodies directed against bromodeoxyuridine with pyrimidine bases, nucleosides, and DNA.
Miller MR; Heyneman C; Walker S; Ulrich RG
J Immunol; 1986 Mar; 136(5):1791-5. PubMed ID: 3950402
[TBL] [Abstract][Full Text] [Related]
30. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
[TBL] [Abstract][Full Text] [Related]
31. The requirement of DNA synthesis for the induction of alkaline phosphatase by bromodeoxyuridine in a derivative of the HeLa cell line.
Morrow J; Stocco DM; Fralick JA
J Cell Physiol; 1979 Feb; 98(2):427-36. PubMed ID: 422667
[TBL] [Abstract][Full Text] [Related]
32. The oxidative stress response is region specific in organogenesis stage mouse embryos exposed to 5-bromo-2'-deoxyuridine.
Gnanabakthan N; Hales BF
Birth Defects Res A Clin Mol Teratol; 2009 Mar; 85(3):202-10. PubMed ID: 19161159
[TBL] [Abstract][Full Text] [Related]
33. Cytochemical characteristics of leukopoietic differentiation in murine erythroleukemic (Friend) cells.
Fioritoni G; Bertolini L; Torlontano G; Revoltella R
Cancer Res; 1980 Mar; 40(3):866-72. PubMed ID: 6937242
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
[TBL] [Abstract][Full Text] [Related]
35. Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell line.
Francastel C; Groisman R; Pfarr CM; Robert-Lézénès J
Oncogene; 1994 Jul; 9(7):1957-64. PubMed ID: 8208542
[TBL] [Abstract][Full Text] [Related]
36. Suppression of tyrosinase gene expression by bromodeoxyuridine in Syrian hamster melanoma cells is not due to its incorporation into upstream or coding sequences of the tyrosinase gene.
Rauth S; Davidson RL
Somat Cell Mol Genet; 1993 May; 19(3):285-93. PubMed ID: 8332936
[TBL] [Abstract][Full Text] [Related]
37. [Delayed disruption of the telomeric links between chromosomes in experimentally induced cells with micronuclei exposed to 5-bromodeoxyuridine in the 1st S period after colcemid administration].
Stobetskiĭ VI; Mironova LL
Tsitologiia; 1987 Jun; 29(6):724-7. PubMed ID: 3629717
[TBL] [Abstract][Full Text] [Related]
38. RNA polymerase II inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptional activation of erythroid genes.
Hensold JO; Barth D; Stratton CA
J Cell Physiol; 1996 Jul; 168(1):105-13. PubMed ID: 8647904
[TBL] [Abstract][Full Text] [Related]
39. [Growth and differentiation of Friend erythroleukemic cells (FLC) in serum-free culture systems].
Jemma C; Covelli A; Peschle C; Rossi GB
Ann Ist Super Sanita; 1982; 18(3):445-6. PubMed ID: 6964822
[No Abstract] [Full Text] [Related]
40. Bromodeoxyuridine resistance: thymidine transport and phosphorylation in Friend leukemia cells.
Keller P; Zownir O; Morrow J
Mutat Res; 1984 Mar; 126(1):53-62. PubMed ID: 6583506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
